Cancer has been a global issue, claiming millions of lives each year. Cancer is characterized by uncontrolled cell growth and has over 100 different types, each with its own set of treatment approaches. PanTum has pioneered a game-changing solution: a 99% successful Early Cancer Detection Test. This breakthrough enables you to predict the likelihood of cancer even before it develops.
While the risk of cancer increases with age, it can affect people of any age, including children.
Early detection through screenings can significantly improve the likelihood of successful treatment and survival.
We developed a 99% successful early cancer detection test called Pantum. You can now check for cancer even before it starts.
With over 1,011 candidates analyzed across various tumor entities, the test has already proven its capabilities, as its scorecard is:
PanTum will not only help to prevent cancer-related deaths by screening healthy people on a regular basis, but it will also significantly reduce the cost and burden on the healthcare system. It represents a true breakthrough in cancer treatment!
It employs EDIM (Epitode Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 and TKTL1 in immune cells (macrophages), which are detectable at various stages of tumor development.
It employs EDIM (Epitode Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 and TKTL1 in immune cells (macrophages), which are detectable at various stages of tumor development.